Abstract
Resistance to Leishmania major in mice is associated with the appearance of distinct T helper type 1 (Th1) and Th2 subsets. T cells from lymph nodes draining cutaneous lesions of resistant mice are primarily interferon gamma (IFN-gamma)-producing Th1 cells. In contrast, T cells from susceptible mice are principally Th2 cells that generate interleukin 4 (IL-4). Although existing evidence is supportive of a role for IFN-gamma in the generation of Th1 cells, additional factors may be required for a protective response to be maintained. A potential candidate is IL-12, a heterodimeric cytokine produced by monocytes and B cells that has multiple effects on T and natural killer cell function, including inducing IFN-gamma production. Using an experimental leishmanial model we have observed that daily intraperitoneal administration at the time of parasite challenge of either 0.33 micrograms IL-12 (a consecutive 5 d/wk for 5 wk) or 1.0 micrograms IL-12 per mouse (only a consecutive 5 d) caused a > 75% reduction in parasite burden at the site of infection, in highly susceptible BALB/c mice. Delay of treatment by 1 wk had less of a protective effect. Concomitant with these protective effects was an increase in IFN-gamma and a decrease in IL-4 production, as measured by enzyme-linked immunosorbent assay of supernatants generated from popliteal lymph node cells stimulated with leishmanial antigen in vitro. The reduction in parasite numbers induced by IL-12 therapy was still apparent at 10 wk postinfection. In addition, we observed that the administration of a rabbit anti-recombinant murine IL-12 polyclonal antibody (200 micrograms i.p. every other day for 25 d) at the time of infection to resistant C57Bl/6 mice exacerbated disease. These effects were accompanied by a shift in IFN-gamma production in vitro by antigen-stimulated lymph node cells indicative of a Th2-like response. These findings suggest that IL-12 has an important role in initiating a Th1 response and protective immunity.
MeSH Terms
Animals
Female
Immunity, Innate/drug effects
Interferon-gamma/biosynthesis
Interleukin-12
Interleukins/pharmacology
Leishmania tropica
Leishmaniasis, Cutaneous/immunology,therapy
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Recombinant Proteins/pharmacology
T-Lymphocytes, Helper-Inducer/drug effects,immunology
Chemicals
Interleukins
Recombinant Proteins
Interleukin-12
Interferon-gamma
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Sypek J P
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
Chung C L
Mayor S E
Subramanyam J M
Goldman S J
Sieburth D S
Wolf S F
Schaub R G
References (20)
20 references, click to expand
-
Use of staphylococcal protein A as an immunological reagent.
J Immunol Methods. 1978;20:241-53
PMID: 349081
-
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.
J Immunol. 1986 Apr 1;136(7):2348-57
PMID: 2419430
-
Cell contact-mediated macrophage activation for antileishmanial defense. I. Lymphocyte effector mechanism that is contact dependent and noncytotoxic.
J Immunol. 1984 Dec;133(6):3358-65
PMID: 6208278
-
Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.
J Immunol. 1985 Mar;134(3):1609-18
PMID: 2578513
-
Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1.
Nature. 1985 May 23-29;315(6017):333-6
PMID: 2582266
-
Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens.
J Exp Med. 1988 Nov 1;168(5):1675-84
PMID: 2903212
-
Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.
J Immunol. 1989 Jul 1;143(1):266-74
PMID: 2499629
-
Epitopes on CD45R [T200] molecules define differentiation antigens on murine B and T lymphocytes.
J Mol Cell Immunol. 1988;4(2):71-85
PMID: 2475124
-
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
J Exp Med. 1989 Sep 1;170(3):827-45
PMID: 2504877
-
Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.
J Exp Med. 1990 Jan 1;171(1):115-27
PMID: 2104918
-
Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells.
J Immunol. 1990 Mar 1;144(5):1629-39
PMID: 1968485
-
Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells.
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6808-12
PMID: 2204066
-
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.
J Exp Med. 1991 Apr 1;173(4):869-79
PMID: 1672545
-
Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells.
J Immunol. 1991 May 1;146(9):3074-81
PMID: 1673147
-
IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
J Immunol. 1991 Nov 1;147(9):3149-55
PMID: 1833466
-
Antileishmanial defense in macrophages triggered by tumor necrosis factor expressed on CD4+ T lymphocyte plasma membrane.
J Exp Med. 1991 Oct 1;174(4):755-9
PMID: 1680956
-
Cloning and expression of murine IL-12.
J Immunol. 1992 Jun 1;148(11):3433-40
PMID: 1350290
-
Different accessory function for TH1 cells of bone marrow derived macrophages cultured in granulocyte macrophage colony stimulating factor or macrophage colony stimulating factor.
Int Immunol. 1992 Jul;4(7):755-64
PMID: 1386751
-
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.
J Exp Med. 1992 Nov 1;176(5):1387-98
PMID: 1357073
-
Cutaneous leishmaniasis--a case with persistent organisms after treatment in presence of normal immune response.
Am J Trop Med Hyg. 1979 May;28(3):467-71
PMID: 222157